Glenn L Cooper MD

CIK 1046351 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 13, 2011 · Latest: Sept. 13, 2011

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 23, 2019 RGEN S 266 $67.53 $17,963 59,709 Direct -0.44% Disposed 166.7% (price as of 2026-08-20)
May 23, 2019 RGEN S 4,734 $66.91 $316,752 59,975 Direct -7.32% Disposed 169.2% (price as of 2026-08-20)
May 23, 2019 RGEN S 266 $67.53 $17,963 35,709 Direct -0.74% Disposed 166.7% (price as of 2026-08-20)
May 23, 2019 RGEN S 4,734 $66.91 $316,752 35,975 Direct -11.63% Disposed 169.2% (price as of 2026-08-20)
Nov. 30, 2012 FBIOP P 3,811 $4.02 $15,320 43,811 Direct +9.53% Acquired 350.5% (price as of 2026-08-20)
Sept. 21, 2012 RGEN P 3,000 $6.09 $18,270 24,038 Direct +14.26% Acquired 2857.2% (price as of 2026-08-20)
Sept. 21, 2012 RGEN P 2,000 $6.08 $12,160 26,038 Direct +8.32% Acquired 2862.1% (price as of 2026-08-20)
Sept. 21, 2012 RGEN P 5,000 $6.09 $30,450 21,038 Direct +31.18% Acquired 2857.2% (price as of 2026-08-20)
June 22, 2012 FBIOP P 10,000 $5.30 $53,000 40,000 Direct +33.33% Acquired 241.7% (price as of 2026-08-20)
Nov. 9, 2009 RGEN P 5,000 $4.98 $24,900 5,000 Direct — Acquired 3516.4% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 23, 2019 RGEN Stock Option (Right to Buy) Common Stock (24,000) $5.00 Aug. 24, 2019 24,000 Disposed
May 15, 2019 RGEN Stock Option (Right to Buy) Common Stock (2,109) $67.71 May 15, 2029 2,109 Acquired
May 16, 2018 RGEN Stock Option (Right to Buy) Common Stock (3,304) $42.07 May 16, 2028 3,304 Acquired
May 18, 2017 RGEN Stock Option (Right to Buy) Common Stock (2,434) $38.76 May 18, 2027 2,434 Acquired
May 11, 2016 RGEN Stock Option (Right to Buy) Common Stock (3,366) $26.12 May 11, 2026 3,366 Acquired
May 21, 2015 RGEN Stock Option (Right to Buy) Common Stock (1,992) $41.19 May 21, 2025 1,992 Acquired
May 15, 2014 RGEN Stock Option (Right to Buy) Common Stock (3,696) $18.12 May 15, 2024 3,696 Acquired
Feb. 10, 2012 FBIOP Options to purchase Common Stock Common Stock (45,000) $6.25 Feb. 10, 2022 45,000 Acquired
Dec. 15, 2011 RGEN Stock Option (Right to Buy) Common Stock (15,000) $3.22 Dec. 15, 2021 15,000 Acquired
Sept. 16, 2010 RGEN Stock Option (Right to Buy) Common Stock (20,000) $3.30 Sept. 16, 2020 20,000 Acquired
Aug. 24, 2009 RGEN Stock Option (Right to Buy) Common Stock (24,000) $5.00 Aug. 24, 2019 24,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 13, 2011 FBIOP Options to purchase Common Stock→ Common Stock (290,235) 290,235 Direct
Sept. 13, 2011 FBIOP Series C Convertible Preferred Stock→ Common Stock (30,000) 30,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

FBIOP

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2011 $225,000 — — — — — $97,500 $322,500

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.